IgAs Against Acetaldehyde‐Modified Red Cell Protein as a Marker of Ethanol Consumption in Male Alcoholic Subjects, Moderate Drinkers, and Abstainers
- 29 September 2006
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 30 (10) , 1693-1698
- https://doi.org/10.1111/j.1530-0277.2006.00204.x
Abstract
Alcohol abuse has been shown to result in the production of antibodies against acetaldehyde-modified epitopes in proteins. However, as yet, only limited information has been available on the clinical usefulness of such responses as markers of hazardous drinking. We developed an ELISA to measure specific IgAs against acetaldehyde-protein adducts. This method was evaluated in cross-sectional and follow-up studies on male heavy drinkers with a current ethanol consumption of 40 to 540 g/d (n=40), moderate drinkers consuming 1 to 40 g/d (n=25), and abstainers (n=16). The clinical assessments included detailed interviews on the amounts and patterns of ethanol consumption and various biochemical markers of alcohol abuse and liver function. The mean antiadduct IgAs (198+/-28 U/L) in the alcohol abusers were significantly higher than those in the moderate drinkers (58+/-11 U/L, p<0.001) or abstainers (28+/-8 U/L, p<0.001). The values of moderate drinkers were also higher than those in abstainers (p<0.05). The amount of ethanol consumed during the period of 1 month preceding blood sampling correlated strongly with antiadduct IgAs (r=0.67, p<0.001). The sensitivity (73%) and specificity (94%) of this marker were found to exceed those of the conventional laboratory markers of alcohol abuse in comparisons contrasting heavy drinkers with abstainers although not in comparisons contrasting heavy drinkers with moderate drinkers. During abstinence, antiadduct IgAs disappeared with a mean rate of 3% per day. In additional analyses of possible marker combinations, antiadduct IgAs, together with CDT, were found to provide the highest sensitivity and specificity. Measurements of antiadduct IgAs may provide a new clinically useful marker of alcohol abuse, providing a close relationship between marker levels and the actual amounts of recent ethanol ingestion.Keywords
This publication has 10 references indexed in Scilit:
- Immune Responses to Ethanol Metabolites and Cytokine Profiles Differentiate Alcoholics with or without Liver DiseaseAmerican Journal of Gastroenterology, 2005
- Improved Diagnostic Classification of Alcohol Abusers by Combining Carbohydrate-deficient Transferrin and γ-GlutamyltransferaseClinical Chemistry, 2001
- Serum IgG and IgE antibodies against mold-derived antigens in patients with symptoms of hypersensitivityClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Comparison of Carbohydrate-Deficient Transferrin, Immunoglobulin A Antibodies Reactive with Acetaldehyde-Modified Protein and Acetaldehyde-Modified Albumin with Conventional Markers of Alcohol ConsumptionAlcohol, Clinical and Experimental Research, 1998
- Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed ratsGastroenterology, 1998
- Inhibition of Intracolonic Acetaldehyde Production and Alcoholic Fermentation in Rats by CiprofloxacinAlcohol, Clinical and Experimental Research, 1998
- Relationship Between Alcohol Intake and Immunoglobulin A Immunoreactivity with Acetaldehyde‐Modified Bovine Serum AlbuminAlcohol, Clinical and Experimental Research, 1996
- Immunoglobulin a antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitisGastroenterology, 1992
- Immunoglobulin A in the diagnosis of alcoholic liver diseaseGastroenterology, 1988
- Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts.Proceedings of the National Academy of Sciences, 1986